Nancy Zhu

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study

Rena Buckstein, Richard A. Wells, Nancy Zhu et al. · British Journal of Haematology · 2016 · 97 citations · Full text

Medicine, Biostatistics, Frailty +16

Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study

Guillermo Garcia‐Manero, James McCloskey, Elizabeth A. Griffiths et al. · The Lancet Haematology · 2023 · 85 citations

Medicine, Pharmacokinetics, Pharmacology +13

Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia

Lewinda Knowles, Jane A. Buxton, Nataliya Skuridina et al. · Harm Reduction Journal · 2009 · 83 citations · Full text

Pharmacy, Toxicology, Case Finding +13

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

Guillermo Garcia‐Manero, Mikkael A. Sekeres, Miklós Egyed et al. · Leukemia · 2017 · 70 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Overall survival in lower <scp>IPSS</scp> risk <scp>MDS</scp> by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an <scp>MDS</scp>‐<scp>CAN</scp> analysis

Heather A. Leitch, Ambica Parmar, Richard A. Wells et al. · British Journal of Haematology · 2017 · 64 citations · Full text

Medicine, Hematology, Iron Metabolism Disorders +13